GlassScriptPhysician profile
Sandra M Yoo
NPI 1225605272
$2,115.49
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $735 · 2022: $1,381.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $670.28 | 2021-2022 | |
| Janssen Scientific Affairs, LLC | $394.21 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $301.80 | 2021-2022 | |
| Janssen Biotech, INC. | $124.59 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $106.98 | 2021-2022 | |
| Daiichi Sankyo INC. | $86.90 | 2022 | |
| Ardelyx, INC. | $86.74 | 2022 | |
| Qol Medical, LLC | $64.55 | 2021-2022 | |
| Gilead Sciences, INC. | $62.13 | 2021 | |
| Alnylam Pharmaceuticals INC. | $60.22 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $44.82 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $34.78 | 2021-2022 | |
| Organon LLC | $18.32 | 2021 | |
| Ironwood Pharmaceuticals, INC | $15.78 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $15.71 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $14.94 | 2021 | |
| Braintree Laboratories, INC. | $12.74 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sandra Yoo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.